{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T09:45:18Z","timestamp":1649065518116},"reference-count":0,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[1999,6]]},"abstract":"<jats:p>Three molecular typing methods, pulsed-field gel electrophoresis (PFGE), ribotyping, and \nflagellin (<jats:italic>flaA<\/jats:italic>) gene typing, were used to discriminate within a group of 28 <jats:italic>Campylobacter \njejuni<\/jats:italic>, heat-stable serotype 55 (HS55) isolates derived from cases of campylobacter enteritis \noccurring throughout Scotland, including 9 isolates associated with an outbreak. PFGE was \nfound to be most discriminatory, identifying 6 distinct profiles, followed by ribotyping (5 \nprofiles), and then flagellin gene typing (4 profiles). The coincidence of all three genotypic \nmarkers identified a dominant clonal line within the HS55 group, accounting for each of the \noutbreak strains, and for 9 of the 19 sporadic strains. A second, closely related, clonal line \naccounted for a further 5 of the sporadic strains, and also included the HS55 reference strain. \nIdentification and monitoring of such clonal lines should facilitate more effective future \nepidemiological surveillance of <jats:italic>C. jejuni<\/jats:italic>.<\/jats:p>","DOI":"10.1017\/s0950268899002502","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T13:23:42Z","timestamp":1027776222000},"page":"367-375","source":"Crossref","is-referenced-by-count":14,"title":["Molecular epidemiological investigation of an outbreak of \n<i>Campylobacter jejuni<\/i> identifies a dominant clonal line within \nScottish serotype HS55 populations"],"prefix":"10.1017","volume":"122","author":[{"given":"C. S.","family":"HARRINGTON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. M.","family":"THOMSON-CARTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"CARTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[1999,6,1]]},"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268899002502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T19:27:17Z","timestamp":1554578837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268899002502\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S0950268899002502"],"URL":"https:\/\/doi.org\/10.1017\/s0950268899002502","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}